炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 智通财经1月11日讯（编辑 若宇）十大券商最新策略观点新鲜出炉，具体如下： | 券商 | 核心观点 | | --- | --- | | 中信证券 | 继续聚焦资源和传统制造定价权的提升 | | 年西证券 | 把握做多窗口 牛市行情或将继续推进 | | 信达证券 | 市场成交放量风险偏好回升 交易性资金有望回暖接力 | | 中泰证券 | 开年市场新高后或如何演绎? | | 来等班券 | 春季行情短期进入主升阶段 继续聚焦科技成长和周期成长主线 | | 方正证券 | 春季攻势已经展开 配置上建议关注三条主线 | | 浙商证券 | 市场选择直接上攻 均衡配行业、持仓迎春节 | | 光大证券 | 政策红利释放 A股市场热度短期有望延续 | | 东吴证券 | 建议以景气成长为主 | | 中国银河 | A股市场开启"躁动"行情 重点布局结构性投资机会 | 中信证券：继续聚焦资源和传统制造定价权的提升 从当前的量价和风偏指标来看，短期市场热度偏高，但情绪指标还没有转弱迹象，预计主题、小票轮动 的震荡上行格局可能还会延续到两会前后，直至内需预期的上修， ...

东吴证券研报称，全球共享出行市场正经历从人力驱动向自动化转型的关键窗口期，呈现出显著的区域 分化特征。北美关键词：存量博弈与政策封锁。北美网约车市场由Uber与Lyft双寡头垄断，定价权稳 固。Robotaxi领域Waymo一家独大，Tesla激进搅局。受2025年美国商务部软硬件禁令影响，中国 Robotaxi企业面临一定封锁，直接商业化路径困难。欧洲关键词：合规准入与技术缺口。欧洲监管环境 碎片化且严苛，本土车企在L4算法上相对滞后，创造了独特的"混合模式"机遇，"美国/本土平台 + 中国 技术底座"有望突围。Uber、Lyft引入百度Apollo，表明去品牌化的技术输出是攻克欧洲市场的占优解。 中东关键词：蓝海高地。 中东呈现独特的"三高一低"特征，即高客单价、高政策支持、高基建投入、 低能源成本。海湾国家急于摆脱石油依赖，将自动驾驶视为国家战略。中国企业如文远知行、小马智行 等在此获得路权与牌照的双重红利，是当前出海的最佳练兵场和商业化变现区。东南亚关键词：成本倒 挂与两轮生态。东南亚网约车市场庞大但客单价低，人力成本低廉导致Robotaxi在经济账上或出现成本 倒挂。短期内终端Robotaxi大规模 ...

证券日报网讯 1月9日，汇创达发布公告称，公司于2025年9月16日召开第四届董事会第四次会议、2025 年10月10日召开2025年第二次临时股东会，审议通过了关于公司向不特定对象发行可转换公司债券（简 称"本次发行"）的相关议案。公司聘请了浙商证券股份有限公司（简称"浙商证券"）担任公司本次发行 的保荐机构、主承销商，根据《证券发行上市保荐业务管理办法》的相关规定，浙商证券作为公司新聘 请的保荐机构，将完成原保荐机构东吴证券股份有限公司未完成的持续督导工作。鉴于公司保荐机构已 更换，为保证募集资金督导工作的正常进行，保护投资者权益，根据相关规定，近日公司、全资子公司 东莞市聚明电子科技有限公司与招商银行股份有限公司深圳分行、保荐机构浙商证券重新签订了《募集 资金专户四方监管协议》。 （文章来源：证券日报） ...

智通财经APP获悉，东吴证券发布研报称，在AIDC建设加速背景下，电力供需缺口持续放大，燃气轮 机行业有望开启新一轮上行周期。AI数据中心建设带来大量用电需求，且对电力的可靠性、稳定性提 出较高要求。燃机市场替代空间大，看好国内设备商受益机会。 投资建议 在需求爆发+供给受限+国产替代的格局下，燃气轮机行业推荐高额燃机订单持续落地【杰瑞股份】、 聚焦高技术壁垒透平叶片国产替代【应流股份】、燃机缸体与环类主力供应商【豪迈科技】、卡特彼勒 供应商【联德股份】。 风险提示 AI数据中心投资不及预期、国际贸易摩擦、国产替代不及预期。 在AIDC建设加速背景下，电力供需缺口持续放大，燃气轮机行业有望开启新一轮上行周期 ①供需格局：需求端快速释放，而供给受制于供应链约束及3–5年的交付周期显著滞后，2025年全球燃 机意向订单已超80GW，实际可交付产能不足50GW，供需缺口明确；②分功率产品优势：重型燃机具 备大功率、长期稳定运行优势，中小型燃机在灵活性与可靠性方面更具优势，均可适配AIDC用电需 求，其中中小型燃机在数据中心场景下需求弹性更强，相关机组订单增速显著；③区域分布：北美与中 东形成双轮驱动格局，美国电力系 ...

东吴证券研报指出，古井贡酒周期底部报表出清可期，动销韧性强复苏第一梯队有望。从行业节奏来 看，2026年动销抓手仍是大众消费场景，同时从古井自身节奏来看，深度调整期管理团队稳定有助于销 售策略连续性更利于穿越周期；中期而言，古井省内优势稳固，坚定"全国化、次高端"战略，省外规模 化市场有望培育成型和复制。基于短期和中期判断，古井在白酒中投资排序靠前，维持"买入"评级。 ...

Core Insights - The year 2026 marks the beginning of the "14th Five-Year Plan" and is seen as a pivotal moment for China's asset management industry, facing new opportunities amid ongoing international volatility and the transformative impact of AI on investment research [2] - The upcoming HED China Summit aims to address critical questions regarding policy direction, low interest rate challenges, and the potential disruption caused by AI in asset allocation decisions [2] Group 1: Macro Outlook - Dongwu Securities' Chief Economist, Lu Zhe, will provide an in-depth analysis of the "New Cycle of the 14th Five-Year Plan: Asset Allocation Outlook," covering growth and structural targets, fiscal and monetary policy coordination, and trends in exchange rates and commodities [4] - A roundtable discussion featuring experts from major banks will combine macro policy guidance with wealth management experience, offering strategic insights for the industry [4] Group 2: Practical Strategies - The summit will focus on actionable solutions to asset allocation challenges in a low-interest-rate environment, with presentations on global macroeconomic trends and multi-asset strategies [5] - Insights into the futures asset management sector and its investment strategies for 2026 will be shared by industry leaders [6] Group 3: Quantitative Focus - A dedicated forum on "The Next Phase of Chinese Quantitative Strategies" will address key concerns in the quantitative field, including innovations in quantitative stock strategies and the development of cross-border funds [7] - Discussions will also focus on the opportunities for institutional funds in quantitative stock strategies, facilitating connections between quantitative firms and mainstream investors [7] Group 4: Efficient Collaboration - The summit emphasizes practical outcomes by facilitating high-efficiency business connections between mainstream institutional investors and private fund managers through tailored networking opportunities [8] Group 5: Industry Recognition - The "19th Jiefu Honor Night" awards ceremony will recognize outstanding contributions in asset management, insurance, and banking, serving as a benchmark for excellence in the industry [9] - The summit aims to create a high-level exchange platform for industry elites to address challenges and seize opportunities, contributing to the high-quality development of the asset management sector in 2026 [9]

Core Viewpoint - Dongwu Securities initiates coverage on Meili Tianyuan Medical Health (02373) with a "Buy" rating, highlighting its unique "Double Beauty + Double Health" ecosystem, proven acquisition integration capabilities, and excellent operational efficiency, which are expected to drive significant growth in the industry [1] Group 1: Company Overview - The company, established in 1993, has developed a comprehensive beauty and health management service system that includes traditional beauty, medical beauty, and sub-health assessment and intervention [2] - It operates four major brands: Meili Tianyuan, Beili Shi, Xiuker, and Yanyuan, and has strengthened its market position through acquisitions of Nairui'er and Siyuanli, forming a synergistic ecosystem of "life beauty + medical beauty + traditional health + sub-health medical" [2] Group 2: Financial Performance - The company demonstrates strong growth resilience, with revenue increasing from 1.503 billion in 2020 to 2.572 billion in 2024, representing a compound annual growth rate (CAGR) of 11.3% [3] - In the first half of 2025, revenue accelerated to 1.459 billion, a year-on-year increase of 28.2% [3] - Net profit attributable to shareholders rose from 151 million in 2020 to 228 million in 2024, with a year-on-year growth of 34.9% in the first half of 2025, reaching 156 million [3] - Gross margin improved to 49.33% in the first half of 2025, while net margin optimized to 10.67%, reflecting effective cost control and an increase in high-margin business [3] - The company commits to a dividend payout ratio of no less than 50% of net profit attributable to shareholders over the next three years, indicating strong dividend levels [3] Group 3: Industry Outlook - The traditional beauty, light medical beauty, and sub-health sectors are expected to continue expanding, with projected market sizes of 640.2 billion, 415.7 billion, and 29 billion respectively by 2030 [4] - As young consumers increasingly prioritize standardized services and stable experiences, leading companies are expected to gain significant advantages, leading to higher market concentration [4] - The overlapping consumer base in traditional beauty and light medical beauty allows for effective cross-referrals, enhancing customer conversion rates [4] Group 4: Business Synergy and Growth Strategy - The company's core business model exhibits strong synergy, utilizing its extensive and trusted life beauty services as a front-end traffic source to efficiently convert to high-ticket medical beauty and sub-health services, with a cross-business conversion rate of 28.7% in 2024 [5] - The company employs a strategy of "directly operated stores as benchmarks, franchising for coverage," leading to rapid expansion of its store network, which is expected to reach 554 by the end of 2024 [5] - The company has a robust target selection system and post-acquisition digital integration capabilities, as evidenced by the significant improvement in net margin following the acquisition of Nairui'er, showcasing its strong integration and empowerment capabilities [5]

Core Viewpoint - Dongwu Securities initiates coverage on Meili Tianyuan Healthcare (02373) with a "Buy" rating, highlighting its unique "Double Beauty + Double Health" ecological model, proven acquisition integration capabilities, and excellent operational efficiency, which are expected to drive sustained industry leadership and significant growth [1] Group 1: Company Overview - Established in 1993, the company has developed a comprehensive beauty and health management service system covering traditional beauty, medical beauty, and sub-health assessment and intervention [2] - The company owns four major brands: Meili Tianyuan, Beili Shi, Xiuker, and Yanyuan, and has strengthened its industry position through acquisitions of Nairui'er and Siyuanli, forming a synergistic ecological closed loop [2] Group 2: Financial Performance - The company demonstrates strong growth resilience, with revenue increasing from 1.503 billion in 2020 to 2.572 billion in 2024, representing a compound annual growth rate (CAGR) of 11.3% [3] - In the first half of 2025, revenue accelerated to 1.459 billion, a year-on-year increase of 28.2% [3] - Net profit attributable to shareholders rose from 151 million in 2020 to 228 million in 2024, with a year-on-year growth of 34.9% in the first half of 2025, reaching 156 million [3] - Gross margin improved to 49.33% in the first half of 2025, while net margin optimized to 10.67%, reflecting effective cost control and a higher proportion of high-margin business [3] - The company commits to a dividend payout ratio of no less than 50% of net profit attributable to shareholders over the next three years, indicating strong dividend levels [3] Group 3: Industry Outlook - The traditional beauty, light medical beauty, and sub-health sectors are expected to see long-term growth, with market sizes projected to reach 640.2 billion, 415.7 billion, and 29 billion respectively by 2030 [4] - As young consumers increasingly prioritize standardized services and stable experiences, the competitive landscape is expected to consolidate further, benefiting leading companies [4] Group 4: Business Synergy and Growth Strategy - The company's core business model exhibits significant synergy, utilizing its extensive and trusted beauty services as a front-end traffic source to efficiently convert to higher-priced medical beauty and sub-health services, with cross-business conversion rate reaching 28.7% in 2024 [5] - The company employs a strategy of "directly operated stores as benchmarks, franchising for coverage," leading to rapid expansion of its store network, totaling 554 by the end of 2024 [5] - The company has a mature target selection system and post-acquisition digital integration capabilities, as evidenced by the significant improvement in net profit margin following the acquisition of Nairui'er, validating its strong integration and empowerment capabilities [5]

国联民生证券股份有限公司（以下简称"国联民生证券"）凭借并购重组实现跨越式发展。作为新"国九 条"后首个券商并购重组案例，其资产和业绩指标较"十四五"开局跃升超20个位次，整合后的投行、研 究业务跻身全国前列，IPO申报数量稳居行业前四。 此外，南京证券股份有限公司50亿元定增落地，聚焦投行、财富管理等核心业务加大投入；东海证券股 份有限公司则深化战略转型，强化常州本土服务与资源倾斜，业绩实现大幅增长，形成了多元协同的发 展格局。 "十四五"时期，资本市场改革持续深化，服务实体经济能力稳步提升。作为经济大省的江苏，证券行业 在此期间实现跨越式发展，不仅整体实力迈上新台阶，更累计助力企业实现直接融资超7万亿元，服务 客户规模超3200万户，以特色行业文化践行金融向善理念，为全省经济"走在前、做示范"注入强 劲"证"能量，交出了一份分量十足的发展答卷。 多元协同发展 行业综合实力稳步跃升 《证券日报》记者从江苏证监局获悉，"十四五"期间，江苏法人证券公司总资产逼近1.6万亿元，较"十 三五"末增长62%，净资产增幅较全国平均水平高出20个百分点，累计实现净利润868亿元，服务客户规 模超3200万户。机构布局方面 ...

技术路线以MoE架构为核心，早于多数同行布局多模态并行研发 公司全栈自研，研发效率高，截至2025年9月累计投入研发约5亿美元。2025年迭代多个模型：Speech系 列在语音生成领域领先，Hailuo系列视频模型在全球基准测试中位居前列，开源模型MiniMax-M1和M2 在Artificial Analysis榜单表现突出。竞争优势主要体现在三个方面。第一，全球化执行力强。Talkie在海 外AI伴侣赛道领先，海螺AI视频生成用量大，海外市场付费意愿高，避免价格战。第二，双轮模式均 衡。消费者业务提供规模和数据，企业业务保障高毛利和稳定性，抗风险能力较好。第三，研发效率领 先。团队年轻化、扁平化管理，结合MoE和自研基础设施，单位算力产出高。 东吴证券发布研报称，MINIMAX-WP(00100)成立于2021年12月，专注通用人工智能基础技术研发，目 标是构建国际竞争力的多模态大模型，并面向全球市场提供产品和服务。从成立之初，公司就选择全球 化定位，同时布局消费者产品和海外渠道。2025/12/21通过港交所聆讯，12月31日启动港股IPO，股票 代码0100，发行估值461-504亿港元，计划募资超过 ...